According to recent research report by IMARC Group, titled “Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global protein therapeutics market grew at a CAGR of around 7% during 2014-2019. . Looking forward, IMARC Group expects the global market to continue its moderate growth during 2020-2025.
Protein therapeutics are medicinal drugs utilized to treat cancer, diabetes, and neurodegenerative and other disorders. These drugs allow an individualized treatment approach by compensating for the deficiency of an essential protein. Consequently, they are gaining immense popularity around the world.
Market Growth Drivers:
The increasing instances of chronic diseases, in confluence with the development of plasma-derived therapies, represent one of the key factors impelling the global protein therapeutics market growth. Apart from this, governments of different countries are undertaking numerous initiatives for the development of a modernized healthcare system. This, in turn, is increasing the sales of protein therapeutics worldwide. Moreover, the rising awareness among the masses about the benefits of protein therapeutics, such as high efficiency and minimal side effects, are propelling the market growth. Furthermore, the rising cases of coronavirus disease (COVID-19) are creating a positive impact on the protein therapeutics market as they are finding is widely adopting these medicines.
Get a PDF sample for more detailed market insights: https://www.imarcgroup.com/protein-therapeutics-market/requestsample
Protein Therapeutics Market 2020-2025 Competitive Analysis and Segmentation:
The competitive landscape of the protein therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Baxter International Inc.
- Novo Nordisk A/S (Novo Holdings A/S)
- Amgen Inc.
- Csl Behring L.L.C. (CSL Limited)
- Johnson & Johnson
- Abbott Laboratories
- Eli Lilly and Company
- Pfizer Inc.
- Abbvie Inc.
- Biogen Inc.
- Merck & Co. Inc.
The report has segmented the global protein therapeutics market on the basis of product, therapy area, function and region.
Breakup by Product:
- Monoclonal Antibodies (mAbs)
- Human Insulin
- Clotting Factors
- Fusion Protein
Breakup by Therapy Area:
- Metabolic Disorders
- Immunological Disorders
- Hematological Disorders
- Hormonal Disorders
- Genetic Disorders
Breakup by Function:
- Enzymatic and Regulatory Activity
- Special Targeting Activity
- Protein Diagnostics
Breakup by Region:
- North America
- United States
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Explore report description with table of contents: https://www.imarcgroup.com/protein-therapeutics-market
Key highlights of the report:
- Market Performance (2014-2019)
- Market Outlook (2020- 2025)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Report:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal